The human microbiome is essential to our health, but scientists have only begun to understand why. Two researchers set out to ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...

Justin Gaethje’s fighting career came full circle under a pair of night skies nearly two decades apart. In 2008, Gaethje had ...

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, in a deal that would expand the ...

First in a three-part series. This story was produced with support from the Pulitzer Center. In the past four springs, state employees in small planes and a helicopter have combed the skies of ...

Vertex Pharma to buy Crinetics Pharmaceuticals for $10 billion: Boston Wednesday, July 8, 2026, 14:00 Hrs [IST] Vertex Pharmaceuticals Incorporated, a global biotechnology company ...

Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September. HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...

It’s a busy week for the Harrodsburg-Mercer County Tourist Commission with Friday Night On Main returning to Olde Town Park ...

Elson Nash, an education and social impact leader, Senior Fellow at Blue Meridian Partners, and By All Means Senior Fellow at ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

USP’s Diane McCarthy on the emerging standards platform and opportunities for stakeholders to help shape standards evolution.

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for ...